Dr Reddy’s announces commercial launch of anti-covid drug 2-DG; Here are its price and availability

The anti-Covid therapeutic application of 2-DG has been jointly developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories.

from The Financial Express https://ift.tt/3hgoDGx